Skip to content

Role of Physiotherapist in enhancing functional aerobic capacity in pulmonary rehabilitation in Covid-19 Patients.

Role of Physiotherapist in enhancing functional aerobic capacity in pulmonary rehabilitation in Covid-19 Patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/028811
Enrollment
50
Registered
2020-11-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Role of Physiotherapist in enhancing functional aerobic capacity in Pulmonary Rehabilitation in COVID 19 patients-A pilot study.: 1. Introduction to patient about study 2. Benefits of s

Sponsors

Apollo Hospitals Educational and Research Foundation AHERF
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age -20-60 2.Haemoglobin > 9 mmHg 3.Covid positive patientâ??s mild, asymptomatic, moderate symptomatic with mild pneumonia. 4.Respiratory rate less than 30 breaths/min. 5.Spo2 more than 90%. 6.No amputations or prostheses in lower extremities 7.Able to ambulate and ability to complete all study protocol tests 8.Likelihood of good compliance to the protocol. 9.Approval by referring Physician.

Exclusion criteria

Exclusion criteria: 1.Patient has immediate plans to transfer to outside hospital 2.Patient requires significant doses of vasopressors for hemodynamic stability (maintain mean arterial pressure > 60 mm Hg) 3.Patient is mechanically ventilated and requires Fio2â?¯ > 0.8 and/or positive end-expiratory pressure > 12 mm Hg, or has acutely worsening respiratory failure 4.Patient is maintained on neuromuscular paralytic agents 5.Patient has an acute neurologic event (e.g., cerebrovascular accident, subarachnoid haemorrhage, or intracranial haemorrhage) with reassessment for mobility every 24 hours 6.Patient is unresponsive to verbal stimuli 7.Patient has an unstable spine or extremity fracture 8.Patient has a grave prognosis and is transferring to comfort care 9.Patient has an open abdomen with a risk for dehiscence 10.Severe pneumonia and on oxygen therapy. 11.Breathing rate more than 30 breaths / min, spo2 less than 90.

Design outcomes

Primary

MeasureTime frame
1.VO2max.2.Rate of perceived exertion 3.WHOQOL-BREF 4. NODIC-Musculoskeletal questionnaireTimepoint: 7 days

Secondary

MeasureTime frame
1.Improved quality of life. 2. Reduced length of stay. 3. Reduced fatigue and exertion during activities. 4.Improved Vital functions. 5. Improved endurance. 6.Improving immunity.Timepoint: 7 days

Countries

India

Contacts

Public ContactSeema Grover

Indraprastha Apollo Hospitals

seema_g@apollohospitals.com9958819222

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026